Search

Your search keyword '"A. Scalisi"' showing total 20 results
Start Over Author "A. Scalisi" Journal journal of hepatology
20 results on '"A. Scalisi"'

1. WED-336 RESIST-NASH: a regional network for identification and referral of masld patients at risk for liver fibrosis

Author

Pennisi, Grazia, primary, Buscemi, Silvio, additional, Bertino, Gaetano, additional, Frittitta, Lucia, additional, Purrello, Francesco, additional, Raimondo, Giovanni, additional, Cartabellotta, Fabio, additional, Russello, Maurizio, additional, Malizia, Giuseppe, additional, Carroccio, Antonio, additional, Tuttolomondo, Antonino, additional, Camilleri, Salvatore, additional, Magrì, Giovanni, additional, Licata, Anna, additional, Cefalù, Angelo Baldassare, additional, Distefano, Marco, additional, Giordano, Carla, additional, Iaria, Chiara, additional, Scalisi, Ignazio, additional, Tullio, Prestileo, additional, Arpi, Maria Luisa, additional, Marco, Vito Di, additional, Camma, Calogero, additional, and Petta, Salvatore, additional

Published
2024
Full Text
View/download PDF

2. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

Author

Cabibbo, Giuseppe, Celsa, Ciro, Calvaruso, Vincenza, Petta, Salvatore, Cacciola, Irene, Cannavò, Maria Rita, Madonia, Salvatore, Rossi, Margherita, Magro, Bianca, Rini, Francesca, Distefano, Marco, Larocca, Licia, Prestileo, Tullio, Malizia, Giuseppe, Bertino, Gaetano, Benanti, Francesco, Licata, Anna, Scalisi, Ignazio, Mazzola, Giovanni, Di Rosolini, Maria Antonietta, Alaimo, Giuseppe, Averna, Alfonso, Cartabellotta, Fabio, Alessi, Nicola, Guastella, Salvatore, Russello, Maurizio, Scifo, Gaetano, Squadrito, Giovanni, Raimondo, Giovanni, Trevisani, Franco, Craxì, Antonio, Di Marco, Vito, and Cammà, Calogero

Published
2019
Full Text
View/download PDF

3. Second-generation DAAs for HCV: real-life efficacy in the resist-HCV cohort

Author

Cacciola, Irene, primary, Petta, Salvatore, additional, Calvaruso, Vincenza, additional, Distefano, Marco, additional, Scifo, Gaetano, additional, Di Lorenzo, Francesco, additional, Sanfilippo, Adriana, additional, Di Rosolini, Maria Antonietta, additional, Davì, Antonio, additional, Benanti, Francesco, additional, Cacopardo, Bruno, additional, Licata, Anna, additional, Giannitrapani, Lydia, additional, Cannavò, Maria Rita, additional, Russello, Maurizio, additional, Madonia, Salvatore, additional, Bavetta, Maria Grazia, additional, Digiacomo, Antonio, additional, Averna, Alfonso, additional, La Rocca, Licia Nunzia, additional, Bertino, Gaetano, additional, Bronte, Fabrizio, additional, Guarneri, Luigi, additional, Scalisi, Ignazio, additional, Iacobello, Carmelo, additional, Colletti, Pietro, additional, Cartabellotta, Fabio, additional, Alaimo, Giuseppe, additional, Vincenzo, Portelli, additional, Pollicino, Teresa, additional, Silberstein, Francesca Ceccherini, additional, Squadrito, Giovanni, additional, Raimondo, Giovanni, additional, Craxi, Antonio, additional, and Di Marco, Vito, additional

Published
2020
Full Text
View/download PDF

4. Second-generation DAAs for HCV: real-life efficacy in the resist-HCV cohort

Author

Irene Cacciola, Salvatore Petta, Vincenza Calvaruso, Marco Distefano, Gaetano Scifo, Francesco Di Lorenzo, Adriana Sanfilippo, Maria Antonietta Di Rosolini, Antonio Davì, Francesco Benanti, Bruno Cacopardo, Anna Licata, Lydia Giannitrapani, Maria Rita Cannavò, Maurizio Russello, Salvatore Madonia, Maria Grazia Bavetta, Antonio Digiacomo, Alfonso Averna, Licia Nunzia La Rocca, Gaetano Bertino, Fabrizio Bronte, Luigi Guarneri, Ignazio Scalisi, Carmelo Iacobello, Pietro Colletti, Fabio Cartabellotta, Giuseppe Alaimo, Portelli Vincenzo, Teresa Pollicino, Francesca Ceccherini Silberstein, Giovanni Squadrito, Giovanni Raimondo, Antonio Craxi, and Vito Di Marco

Subjects
Hepatology
Published
2020
Full Text
View/download PDF

5. Disease outcomes after DAA-induced SVR: data from the resist-HCV cohort

Author

Calvaruso, V., primary, Petta, S., additional, Cacciola, I., additional, Cabibbo, G., additional, Fabio, C., additional, DI Rosolini, M.A., additional, Davì, A., additional, Cannavò, M.R., additional, Russello, M., additional, Di Stefano, M., additional, Scifo, G., additional, DI Lorenzo, F., additional, Tullio, P., additional, Larocca, L.N., additional, Montineri, A., additional, Fuduli, G., additional, DI Giacomo, A., additional, Cannizzaro, M., additional, Madonia, S., additional, Licata, A., additional, Malizia, G., additional, Alaimo, G., additional, Bertino, G., additional, Cacopardo, B., additional, Iacobello, C., additional, Averna, A., additional, Guarneri, L., additional, Scalisi, I., additional, Mazzola, G., additional, Mondello, L., additional, Vincenzo, P., additional, Squadrito, G., additional, Camma, C., additional, Raimondo, G., additional, Craxi, A., additional, and DI Marco, V., additional

Published
2018
Full Text
View/download PDF

6. THU414 - Second-generation DAAs for HCV: real-life efficacy in the resist-HCV cohort

Author

Cacciola, Irene, Petta, Salvatore, Calvaruso, Vincenza, Distefano, Marco, Scifo, Gaetano, Di Lorenzo, Francesco, Sanfilippo, Adriana, Di Rosolini, Maria Antonietta, Davì, Antonio, Benanti, Francesco, Cacopardo, Bruno, Licata, Anna, Giannitrapani, Lydia, Cannavò, Maria Rita, Russello, Maurizio, Madonia, Salvatore, Bavetta, Maria Grazia, Digiacomo, Antonio, Averna, Alfonso, La Rocca, Licia Nunzia, Bertino, Gaetano, Bronte, Fabrizio, Guarneri, Luigi, Scalisi, Ignazio, Iacobello, Carmelo, Colletti, Pietro, Cartabellotta, Fabio, Alaimo, Giuseppe, Vincenzo, Portelli, Pollicino, Teresa, Silberstein, Francesca Ceccherini, Squadrito, Giovanni, Raimondo, Giovanni, Craxi, Antonio, and Di Marco, Vito

Published
2020
Full Text
View/download PDF

7. Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antivirals

Author

C. Cammà, M.A.D. Stefano, Lydia Giannitrapani, G. Scifo, S. Madonia, S. Petta, A. Digiacomo, Antonio Craxì, G. Raimondo, L. Guarneri, Giuseppe Cabibbo, A. Ardiri, A. Davì, A. Magro, M. Gussio, Maurizio Russello, Vincenza Calvaruso, I. Scalisi, L. Larocca, Fabio Tinè, A. Bellia, Irene Cacciola, F. Savalli, V. Di Marco, Giovanni Mazzola, Giovanni Squadrito, and F. Cartabellotta

Subjects
0301 basic medicine, Hepatology, business.industry, Hepatitis C virus, 030106 microbiology, medicine.disease_cause, medicine.disease, DIRECT ACTING ANTIVIRALS, Virology, 03 medical and health sciences, Liver disease, 0302 clinical medicine, Hepatocellular carcinoma, Medicine, 030211 gastroenterology & hepatology, In patient, business
Published
2017
Full Text
View/download PDF

8. Efficacy and safety of 12-week DAA regimens in HCV genotype 1b patients with compensated cirrhosis: data of RESIST-HCV Cohort

Author

Madonia, S., primary, Calvaruso, V., additional, Filomia, R., additional, Cannavò, M.R., additional, Di Stefano, M., additional, Russello, M., additional, Davì, A., additional, Scifo, G., additional, Volpes, R., additional, Montineri, A., additional, Ficalora, R., additional, Malizia, G., additional, Digiacomo, A., additional, Bertino, G., additional, Alaimo, G., additional, Licata, A., additional, Cacopardo, B., additional, Averna, A., additional, Guarneri, L., additional, Scalisi, I., additional, Colletti, P., additional, Cartabellotta, F., additional, Savalli, F., additional, Cannizzaro, M., additional, Raimondo, G., additional, Craxì, A., additional, and Di Marco, V., additional

Published
2017
Full Text
View/download PDF

9. Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antivirals

Author

Calvaruso, V., primary, Cabibbo, G., additional, Cacciola, I., additional, Petta, S., additional, Madonia, S., additional, Bellia, A., additional, Stefano, M.D., additional, Giannitrapani, L., additional, Tinè, F., additional, Magro, A., additional, Davì, A., additional, Larocca, L., additional, Ardiri, A., additional, Digiacomo, A., additional, Gussio, M., additional, Guarneri, L., additional, Scalisi, I., additional, Mazzola, G., additional, Cartabellotta, F., additional, Savalli, F., additional, Russello, M., additional, Scifo, G., additional, Squadrito, G., additional, Cammà, C., additional, Raimondo, G., additional, Craxì, A., additional, and Di Marco, V., additional

Published
2017
Full Text
View/download PDF

10. Non-invasive tools to ruling out large varices: RESIST-HCV vs. Baveno VI criteria in a large cohort of patients with HCV cirrhosis

Author

Calvaruso, V., primary, Cacciola, I., additional, Licata, A., additional, Madonia, S., additional, Benigno, R., additional, Bronte, F., additional, Petta, S., additional, Malizia, G., additional, Bertino, G., additional, Di Stefano, M., additional, Volpes, R., additional, Montineri, A., additional, Di Giacomo, A., additional, Alaimo, G., additional, Cacopardo, B., additional, Guarneri, L., additional, Scalisi, I., additional, Mazzola, G., additional, Cartabellotta, F., additional, Portelli, V., additional, Russello, M., additional, Squadrito, G., additional, Raimondo, G., additional, Craxì, A., additional, and Di Marco, V., additional

Published
2017
Full Text
View/download PDF

11. Efficacy of oral Direct Acting Antivirals for the treatment of chronic hepatitis/cirhhosis due to hepatitis C virus infection: the real-life experience of the Sicily Registry

Author

Cacciola, I., primary, Petta, S., additional, Di Stefano, M., additional, Cannavò, M.R., additional, Davì, A., additional, Madonia, S., additional, Calvaruso, V., additional, Rocca, L.L., additional, Di Lorenzo, F., additional, Digiacomo, A., additional, Bertino, G., additional, Licata, A., additional, Benanti, F., additional, Volpes, R., additional, Guarneri, L., additional, Averna, A., additional, Scalisi, I., additional, Iacobello, C., additional, Colletti, P., additional, Cartabellotta, F., additional, Portelli, V., additional, Russello, M., additional, Scifo, G., additional, Squadrito, G., additional, Raimondo, G., additional, Craxì, A., additional, and Di Marco, V., additional

Published
2017
Full Text
View/download PDF

12. Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals

Author

Cabibbo, G., primary, Cacciola, I., additional, Cannavò, M.R., additional, Madonia, S., additional, Calvaruso, V., additional, Petta, S., additional, Di Stefano, M., additional, Larocca, L., additional, Prestileo, T., additional, Tinè, F., additional, Digiacomo, A., additional, Bertino, G., additional, Giannitrapani, L., additional, Benanti, F., additional, Davì, A., additional, Volpes, R., additional, Guarneri, L., additional, Averna, A., additional, Scalisi, I., additional, Iacobello, C., additional, Mazzola, G., additional, Cartabellotta, F., additional, Portelli, V., additional, Russello, M., additional, Scifo, G., additional, Squadrito, G., additional, Raimondo, G., additional, Craxì, A., additional, Di Marco, V., additional, and Cammà, C., additional

Published
2017
Full Text
View/download PDF

13. PS-149 - Disease outcomes after DAA-induced SVR: data from the resist-HCV cohort

Author

Calvaruso, V., Petta, S., Cacciola, I., Cabibbo, G., Fabio, C., DI Rosolini, M.A., Davì, A., Cannavò, M.R., Russello, M., Di Stefano, M., Scifo, G., DI Lorenzo, F., Tullio, P., Larocca, L.N., Montineri, A., Fuduli, G., DI Giacomo, A., Cannizzaro, M., Madonia, S., Licata, A., Malizia, G., Alaimo, G., Bertino, G., Cacopardo, B., Iacobello, C., Averna, A., Guarneri, L., Scalisi, I., Mazzola, G., Mondello, L., Vincenzo, P., Squadrito, G., Camma, C., Raimondo, G., Craxi, A., and DI Marco, V.

Published
2018
Full Text
View/download PDF

14. Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals

Author

Vincenza Calvaruso, I. Scalisi, G. Scifo, Giuseppe Cabibbo, Riccardo Volpes, Gaetano Bertino, Fabio Tinè, F. Benanti, F. Cartabellotta, V. Di Marco, V. Portelli, Giovanni Squadrito, L. Larocca, A. Averna, Tullio Prestileo, Maurizio Russello, L. Guarneri, S. Petta, S. Madonia, Giovanni Mazzola, Lydia Giannitrapani, G. Raimondo, A. Davì, M. Di Stefano, Antonio Craxì, C. Cammà, M.R. Cannavò, Irene Cacciola, Carmelo Iacobello, and A. Digiacomo

Subjects
medicine.medical_specialty, Hepatology, business.industry, Hepatocellular carcinoma, Internal medicine, medicine, Hepatitis C, medicine.disease, business, DIRECT ACTING ANTIVIRALS, Gastroenterology
Published
2017
Full Text
View/download PDF

15. SAT-267 - Efficacy and safety of 12-week DAA regimens in HCV genotype 1b patients with compensated cirrhosis: data of RESIST-HCV Cohort

Author

Madonia, S., Calvaruso, V., Filomia, R., Cannavò, M.R., Di Stefano, M., Russello, M., Davì, A., Scifo, G., Volpes, R., Montineri, A., Ficalora, R., Malizia, G., Digiacomo, A., Bertino, G., Alaimo, G., Licata, A., Cacopardo, B., Averna, A., Guarneri, L., Scalisi, I., Colletti, P., Cartabellotta, F., Savalli, F., Cannizzaro, M., Raimondo, G., Craxì, A., and Di Marco, V.

Published
2017
Full Text
View/download PDF

16. SAT-012 - Non-invasive tools to ruling out large varices: RESIST-HCV vs. Baveno VI criteria in a large cohort of patients with HCV cirrhosis

Author

Calvaruso, V., Cacciola, I., Licata, A., Madonia, S., Benigno, R., Bronte, F., Petta, S., Malizia, G., Bertino, G., Di Stefano, M., Volpes, R., Montineri, A., Di Giacomo, A., Alaimo, G., Cacopardo, B., Guarneri, L., Scalisi, I., Mazzola, G., Cartabellotta, F., Portelli, V., Russello, M., Squadrito, G., Raimondo, G., Craxì, A., and Di Marco, V.

Published
2017
Full Text
View/download PDF

17. FRI-228 - Efficacy of oral Direct Acting Antivirals for the treatment of chronic hepatitis/cirhhosis due to hepatitis C virus infection: the real-life experience of the Sicily Registry

Author

Cacciola, I., Petta, S., Di Stefano, M., Cannavò, M.R., Davì, A., Madonia, S., Calvaruso, V., Rocca, L.L., Di Lorenzo, F., Digiacomo, A., Bertino, G., Licata, A., Benanti, F., Volpes, R., Guarneri, L., Averna, A., Scalisi, I., Iacobello, C., Colletti, P., Cartabellotta, F., Portelli, V., Russello, M., Scifo, G., Squadrito, G., Raimondo, G., Craxì, A., and Di Marco, V.

Published
2017
Full Text
View/download PDF

18. THU-096 - Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals

Author

Cabibbo, G., Cacciola, I., Cannavò, M.R., Madonia, S., Calvaruso, V., Petta, S., Di Stefano, M., Larocca, L., Prestileo, T., Tinè, F., Digiacomo, A., Bertino, G., Giannitrapani, L., Benanti, F., Davì, A., Volpes, R., Guarneri, L., Averna, A., Scalisi, I., Iacobello, C., Mazzola, G., Cartabellotta, F., Portelli, V., Russello, M., Scifo, G., Squadrito, G., Raimondo, G., Craxì, A., Di Marco, V., and Cammà, C.

Published
2017
Full Text
View/download PDF

19. PS-038 - Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antivirals

Author

Calvaruso, V., Cabibbo, G., Cacciola, I., Petta, S., Madonia, S., Bellia, A., Stefano, M.D., Giannitrapani, L., Tinè, F., Magro, A., Davì, A., Larocca, L., Ardiri, A., Digiacomo, A., Gussio, M., Guarneri, L., Scalisi, I., Mazzola, G., Cartabellotta, F., Savalli, F., Russello, M., Scifo, G., Squadrito, G., Cammà, C., Raimondo, G., Craxì, A., and Di Marco, V.

Published
2017
Full Text
View/download PDF

20. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon

Author

Fattovich, G., Giustina, G., Favarato, S., Ruol, A., Macarri, G., Orlandi, E., Iaquinto, G., Ambrosone, L., Francavilla, A., Pastore, G., Santantonio, M. T., Romagno, D., Bolondi, L., Sofia, S., Marchesini, A., Pisi, E., Mazzella, G., Roda, E., Attaro, L., Chiodo, E., Mori, E., Verucchi, G., Lanzini, A., Salmi, A., Calvi, B., Bozzetti, E., Radaeli, E., Bernasconi, M., Pilleri, G., Bacca, D., Romano, G., Mastrapasqua, G., Cozzolongo, R., Cacopardo, B., Nunnari, A., Blasi, A., Sala, L. O., Minoli, G., Sangiovanni, A., Spinzi, G. C., Colombo, A., Camassa, M., Riva, D., Maggi, G., Boccia, S., Gualandi, G., Nucci, A., Pacini, F., Marino, N., Mazzotta, E., La Mura, A., Pompei, A. G., Casinelli, K., Petrosillo, N., Giacchino, R., Timitilli, A., Spiga, E., Corsetti, M., Menicagli, V., Tucci, A., Bissoli, E., Raimondo, G., Rodino, G., Bellobuono, A., Ideo, G., Colombo, M., Pacchetti, S., Rumi, M. R., Battezzati, P. M., Bruno, S., Podda, M., Zuin, M., Fargion, S., Fiorelli, G., Gellmann, E., Vandelli, C., Ventura, E., Manenti, F., Villa, E., Caporaso, N., Coltorti, M., Morisco, E., Del Vecchio-Blanco, C., di Santolo, S. S., Di Nunzio, S., Ruggiero, G., Zampino, R., Ascione, A., De Luca, M., Galeota-Lanza, A., Aprea, L., Sagnelli, E., Felaco, E. M., Piccinino, E., Ballare, M., Monteverde, A., Tappero, G., Sanna, G., Alberti, A., Bonetti, P., Casarin, C., Diodati, G., Tremolada, E., Naccarato, R., Chiaramonte, M., Floreani, M. R., Almasio, P., Craxi, A., Loiacono, O., Pagliaro, L., Fiaccadori, E., Giuberti, T., Belloni, G., Bernardini, E., Buscarini, L., Sbolli, G., Giudici-Cipriani, A., Marenco, G., Mazzaro, C., Massari, M., Fornaciari, G., Plancher, A., Gasbarrini, G., Grieco, A., Luchetti, R., Rapaccini, G. L., Bombardieri, G., Di Virgilio, D., Bruno, G., Ricci, G. L., Hassan, G., Mari, T., Scalisi, I., Colloredo, G., Frunzio, A., Tabone, M., Costa, C., Rosina, E., Saracco, G., Verme, G., Frezza, M., Urban, E., Capra, E., Casaril, M., Corrocher, R., and Benetti, G. P.

Subjects
Adult, Male, medicine.medical_specialty, Adolescent, Hepatitis, Viral, Human, Alpha interferon, Poison control, Chronic viral hepatitis, Interferon alfa, Side effects, Gastroenterology, Autoimmune Diseases, Internal medicine, Medicine, Humans, Adverse effect, Child, Aged, Retrospective Studies, Hepatitis, Hepatology, business.industry, Thyroid disease, Mental Disorders, Infant, Newborn, Infant, Middle Aged, medicine.disease, Recombinant Proteins, Surgery, Bone marrow suppression, Child, Preschool, Chronic Disease, Interferon Type I, Female, business, Viral hepatitis, medicine.drug
Abstract

Aims: The aim of this study was to assess the incidence of fatal, life-threatening side effects and the de novo appearance of non-hepatic morbidity during interferon alfa therapy for chronic viral hepatitis. The relationship of these adverse events to actual total dose and duration of interferon was also evaluated. Methods: We conducted a retrospective study at 73 Italian centers of 11 241 consecutive patients with chronic vital hepatitis who underwent interferon alfa treatment. Results: Five patients died during interferon therapy due to liver failure ( n =4) or complications arising from sepsis. Life-threatening side effects were observed in eight patients: two cases where depression developed and led to a suicide attempt and six patients with bone marrow suppression (granulocytes 3 or platelets 3 ). These symptoms and signs completely disappeared after interferon withdrawal. During interferon treatment, 131 patients developed the following de novo non-hepatic disorders: symptomatic thyroid disease ( n =71), impotence ( n =5), systemic autoimmune disease ( n =5), immune-mediated dermatologic disease ( n =14), diabetes mellitus ( n =10), cardiovascular disease ( n =7), psychosis n =10), seizures ( n =4), peripheral neuropathy ( n =3) and hemolytic anemia ( n =2). Most of these complications are reversible or can be ameliorated. Fatal or life-threatening side effects were not related to actual total dose or duration of interferon alfa, while the majority of patients with de novo non-hepatic morbidity received medium/high doses ( > 200 million units) of interferon alfa or were treated for periods longer than 16 weeks (68% and 80%, respectively). Conclusions: Treatment with interferon alfa may have fatal or life-threatening side effects, their incidence in this study being low (0.04% and 0.07%, respectively) and perhaps no different than in untreated patients with chronic viral hepatitis. Moreover de novo non-hepatic morbidity occurred in 1.2% of patients, and the dose and duration of interferon therapy seem important in determining the frequency of this complication. The development of clinically-overt thyroid disease was most common.

Published
1996

Catalog

Books, media, physical & digital resources
See catalog results